Evidence map›Paper›PMID 30707845›Full record

ArticlePharmaceutical biology2019

Syzygium aromaticum aqueous extract inhibits human neutrophils myeloperoxidase and protects mice from LPS-induced lung inflammation.

Amina Chniguir, Fatma Zioud, Viviana Marzaioli, Jamel El-Benna, Rafik Bachoual

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Molecules (Basel, Switzerland) · 2022
    Article
  8. Review
  9. Roles ofPlants (Basel, Switzerland) · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Molecular Basis of the Therapeutical Potential of Clove (Molecules (Basel, Switzerland) · 2021
    Review
  14. Article
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Amina Chniguira Faculty of Sciences of Gabes , University of Gabes , Gabes , Tunisia.
Fatma Ziouda Faculty of Sciences of Gabes , University of Gabes , Gabes , Tunisia.
Viviana Marzaiolic INSERM U1149 , CNRS ERL8252 Inflammation Research Center , Paris , France.
Jamel El-Bennac INSERM U1149 , CNRS ERL8252 Inflammation Research Center , Paris , France.
Rafik Bachouala Faculty of Sciences of Gabes , University of Gabes , Gabes , Tunisia.
University of Sfax · TNCentre de Recherche sur l'Inflammation · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextSyzygium aromaticum (L.) Merr. & Perry (Myrtaceae), commonly known as clove, originally found in the Muluku Islands in East Indonesia, is widely used as a spice and has numerous medicinal properties.

objectiveThis study investigated the antioxidant potential of S. aromaticum aqueous extract (SAAE) in vitro and its protective effects on lipopolysaccharide (LPS)-induced lung inflammation in mice. MATERIAL AND

methodsNeutrophils were isolated from healthy donors and reactive oxygen species (ROS) generation was measured by luminol-amplified chemiluminescence. Superoxide anion generation was detected by cytochrome c reduction assay. H

resultsSAAE inhibited luminol-amplified chemiluminescence of resting neutrophils and N-formyl-methionyl-leucyl-phenylalanine- or phorbol myristate acetate-stimulated neutrophils, with an inhibitory effect starting at a concentration as low as 0.5 µg/mL. Moreover, SAAE reduced significantly MPO activity and it exhibits a dose-dependent action (IC DISCUSSION AND

conclusionOur results suggest that the anti-inflammatory activity of SAAE, in vivo, is due to the inhibition of ROS production and metalloproteinases activity via its action on MPO. According to these findings, SAAE could be a potential source of new compounds with anti-inflammatory activity.

Indexed as

AnimalsHumansHydrogen PeroxideLipopolysaccharidesMiceMice, Inbred BALB CNeutrophilsOxidation-ReductionPeroxidasePlant ExtractsPneumoniaProtective AgentsRandom AllocationReactive Oxygen SpeciesSyzygiumHydrogen PeroxideLipopolysaccharidesPeroxidasePlant ExtractsProtective AgentsReactive Oxygen Speciesbronchoalveolar lavage fluidClovemyeloperoxidasereactive oxygen species

Identifiers

PMID30707845
PMCPMC6366422
OpenAlexW2913391860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.